Recruitment

Recruitment Status
Completed
Estimated Enrollment
20

Summary

Conditions
  • Diabetes
  • Healthy
Type
Interventional
Phase
Phase 1
Design
  • Allocation: Randomized
  • Intervention Model: Crossover Assignment
  • Masking: None (Open Label)
  • Primary Purpose: Treatment

Participation Requirements

Min Age
18
Max Age
64
Gender
Both

Locations

Neuss, 41460
Neuss, 41460

Tracking Information

NCT #
NCT02089451
Collaborators
Not Provided
Investigators
Study Director: Global Clinical Registry (GCR, 1452) Novo Nordisk A/S